Neurons expressing nitric oxide (NO) synthase (nNOS) and thus capable of synthesizing NO play major roles in many aspects of brain function. While the heterogeneity of nNOS-expressing neurons has been studied in various brain regions, their phenotype in the hypothalamus remains largely unknown. Here we examined the distribution of cells expressing nNOS in the postnatal and adult female mouse hypothalamus using immunohistochemistry. In both adults and neonates, nNOS was largely restricted to regions of the hypothalamus involved in the control of bodily func- Altogether, these observations are consistent with the proposed role of nNOS neurons in physiological processes.
| I N T R O D U C T I O N
Nitric oxide (NO) is a chemical transmitter with an extremely diverse role in the mammalian central and peripheral nervous systems (Garthwaite, 2008; Garthwaite, 2016; Steinert, Chernova, & Forsythe, 2010) . Therefore, it comes as no surprise that neurons expressing neuronal NO synthase (nNOS) are represented by a variety of subpopulations of cells that differ in terms of their genetic specification and molecular characterization, with their only common property being their ability to synthesize NO. This heterogeneity in the origins of nNOS cells as well as the nature of the neurotransmitters they may co-express has been studied in several regions of the brain, such as the hippocampus, the neocortex, the nucleus of the solitary tract, and the olfactory bulb (Crespo et al., 2003; Fujimoto, Konno, Watanabe, & Jinno, 2016; Giuili, Luzi, Poyard, & Guellaen, 1994; Lin, 2009; Tricoire & Vitalis, 2012; von Bartheld & Schober, 1997 hypothalamic nNOS neurons play vital roles in the control of reproduction (Gyurko et al., 2002; Hanchate et al., 2012; Messina et al., 2016) and energy homeostasis (Leshan et al., 2012; Sutton et al., 2014) , as well as in the crosstalk between these two vital functions (Bellefontaine et al., 2014) . This crosstalk is also thought to involve, at least in part, GABAergic neurons (Martin et al., 2014; Zuure, Roberts, Quennell, & Anderson, 2013) . Except for partial information from recent studies (Marshall, Desroziers, McLennan, & Campbell, 2016) , the issue of whether GABA and NO are co-synthesized in discrete populations of hypothalamic neurons remains unexplored.
The regulation of reproduction mediated by hypothalamic nNOS neurons is principally thought to occur in the preoptic region at the median preoptic nucleus (MEPO) and the organum vasculosum laminae terminalis (OV), where neurons expressing nNOS and gonadotropinreleasing hormone (GnRH) are co-distributed (d 'Anglemont de Tassigny et al., 2007; Hanchate et al., 2012; Herbison, Simonian, Norris, & Emson, 1996) and interact functionally (Bellefontaine et al., 2014; Clasadonte, Poulain, Beauvillain, & Prevot, 2008) . The activity of nNOS in the preoptic region has been shown to be tightly regulated by circulating estrogen levels (d'Anglemont de Tassigny et al., 2007; Parkash et al., 2010) and to be required for estrous cyclicity (d'Anglemont de Tassigny et al., 2007) . In particular, nNOS activity has been shown to restrain the activity of the hypothalamo-pituitary-gonadal (HPG) axis during phases of the estrous cycle at which circulating levels of estrogens are low, and to be required for the onset of the LH surge induced by gonadal steroids in mice (Hanchate et al., 2012) . Results from recent studies knocking out estrogen receptor alpha (ERa) expression selectively in glutamatergic neurons have shown, unexpectedly, that glutamatergic neurons, which tightly regulate nNOS activity (Garthwaite, Charles, & Chess-Williams, 1988) and have long been known to be potent activators of the HPG axis (Brann & Mahesh, 1991; Claypool, Kasuya, Saitoh, Marzban, & Terasawa, 2000; Urbanski & Ojeda, 1990) , not only play a role in the estrogen-mediated positive-feedback phase, which triggers the preovulatory GnRH surge, but also in the negativefeedback loop (Cheong, Czieselsky, Porteous, & Herbison, 2015) . These findings raise the hitherto unexplored possibility that discrete populations of glutamatergic neurons co-express nNOS in the hypothalamus.
In addition to its regulatory role in the adult, nNOS is also expressed in the hypothalamus during early life (Edelmann, Wolfe, Scordalakes, Rissman, & Tobet, 2007) , suggesting a role for NO in the maturation of GnRH neurons during postnatal development via the regulation of GnRH mRNA expression (Messina et al., 2016) , a phenomenon that could be critical for sexual maturation (Prevot, 2015) .
In the present study, we systematically analyzed the distribution of nNOS in the female mouse hypothalamus during postnatal development and in adulthood. In addition, to determine when nNOS neurons become competent in sensing the estrogenic signal, we studied the dis- 
| Antibody characterization
All primary antibodies used are listed in Table 1 , and the labeling observed corresponded to the cellular morphology and distribution patterns demonstrated in previous publications.
| Immunohistochemistry
Sections were washed three times in PB 0.1M for 5 min each and then microwaved in 10 mM citrate buffer pH 6.0 (4 min at 800 W followed 
| Image acquisition
Images were acquired with a Zeiss Axio Imager Z2 microscope (Zeiss, Germany). Alexa 488 was imaged using a 495 nm beam splitter with an excitation wavelength set at 450/490 nm and an emission wavelength set at 500/550 nm. Alexa 568 was imaged using a 570 nm beam splitter with an excitation wavelength set at 538/562 nm and an emission wavelength set at 570/640 nm. Alexa 647 was imaged by using a 
| Cell counts and analysis
The nomenclature of brain regions used in this article corresponds to that described in the mouse Allen brain atlas (http://mouse.brainmap.
org/experiment/thumbnails/100048576?image_type 5 atlas) (Lein et al., 2007) . The quantification of nNOS neurons co-expressing ERa or 
| R E S U L T S
The immunoreactive signal for nNOS in the CNS is highly abundant in the hypothalamus of female mice (Table 2) , with a particularly dense distribution in the OV and the MEPO ( Figure 1a ). As indicated in Table   2 and below in the text, nNOS immunoreactivity was assessed as being of the "highest density", "high density", "moderate density", "low density", and "undetectable" based on both signal strength and the number of labeled cells. This labeling appeared to be specific because no cellular immunoreactive signal was observed when the same antibody was used on sections obtained from nNOS-null mice (data not shown).
| Expression of nNOS immunoreactivity in adults
In the preoptic area of adult female mice, besides the dense expression of nNOS in the OV/MEPO (Figure 1a ), moderate levels of nNOS labeling were also found in the anteroventral periventricular nucleus (AVPV) (Figure 1b ) and the medial preoptic area (MPO) (Figure 1b ). An nNOS immunoreactive signal was clearly seen in cell bodies of the supraoptic nucleus (SO) (Figure 1c ), the paraventricular hypothalamic nucleus (PVH) (Figure 1d ) and the lateral hypothalamic area (LHA) (Figure 1c ), but appeared to be absent from the suprachiasmatic hypothalamic nucleus (SCH) (Figure 1c ). In the tuberal region of the hypothalamus, nNOS immunoreactivity was also found in neuronal cell bodies of the dorsomedial hypothalamic nucleus (DMH) (Figure 1e ), the ventrolateral part of the ventromedial hypothalamic nucleus (VMHvl) (Figure 1e ), the arcuate nucleus of the hypothalamus (ARH) (Figure 1e ), the LHA, and the ventral premammillary nucleus (PMv) (Figure 1f ), whereas only rare nNOS-immunoreactive cell bodies were seen in the posterior periventricular nucleus (PVp) (Figure 1f ). PMd: premammillary nucleus, dorsal 1(1) 1(1) 11
PH: posterior hypothalamic nucleus 11 11 1(1)
| Expression of nNOS-immunoreactivity in postnatal brains
As shown in Table 2 and Figure 2 , the pattern of nNOS protein expression in the hypothalamus of P11 and P23 animals resembled that of adult mice, with two marked exceptions being the SCH and the ARH.
nNOS immunoreactivity did not appear to vary across postnatal development (Table 2) ,f and 1c) . In contrast, nNOS immunoreactivity was seen to decrease drastically in the SCH between P11 and adulthood (p11: 22.6 6 0.88, p23: 13.67 6 0.88 and adult: 4.66 6 2.73, n 5 3 per group) (Figure 2e,f) . In the tuberal region of the hypothalamus, nNOS expression was consistent between adult and postnatal brains in most nuclei, such as the VMH, DMH, PVp, and PMv (Table 2 ) (Figure 2i-l) .
However, striking differences in nNOS expression depending on age did exist in the ARH. While nNOS-immunoreactive neurons could be easily seen in the ARH of P23 (22.25 6 0.78, n 53) and adult female brains (36.5 6 2.76, n 5 3) (Figures 1e and 2j ), the nNOS signal was totally absent in the ARH at P11 (n 5 3) ( Figure 2i , Table 2 ).
| Subsets of nNOS neurons express ERaimmunoreactivity in the hypothalamus
To determine whether hypothalamic nNOS neurons can sense estrogens during postnatal development, we studied the pattern of ERa 82.04% 6 7.36, adult: 87.59% 6 4.17, n 5 3-4 per group) corresponded to the population of nNOS-expressing neurons, leaving only a few single-labeled ERa-expressing neurons that did not express the nNOS protein (Figures 3a and 4a ). In the AVPV, a hypothalamic structure known to play a key role in mediating the positive feedback of estradiol on the HPG axis (Herbison, 2016) , nNOS neurons, which were much less abundant than in the OV/MEPO, were also seen to express ERa at the different ages analyzed (Figures 3b and 4b ). In the ARH, another key hypothalamic structure involved in the feedback loop of gonadal estrogens (Herbison, 2016; Oakley, Clifton, & Steiner, 2009; Pinilla, Aguilar, Dieguez, Millar, & Tena-Sempere, 2012) , ERa-immunoreactivity was detected as early as P11, as previously reported by others (Brock, De Mees, & Bakker, 2015) , when nNOS immunoreactivity is not yet detectable. At P23, more than 70% of the nNOS-immunoreactive neurons of the ARH already co-expressed ERa (72.65% 6 5.60, n 5 4), a proportion that persisted into adulthood (72.29% 6 7.29, n 5 3) ( Figures   3c and 4d ). In the adult VMH, nNOS-immunoreactive cells located in the ventrolateral part of the nucleus were also seen to extensively
Photomicrographs showing the distribution of nNOS immunoreactivity in distinct hypothalamic nuclei as seen in coronal sections of the adult female mouse brain. nNOS immunoreactivity (white labeling) is readily visualized in neurons of the preoptic area; labeling is evident in the regions of the organum vasculosum laminae terminalis (OV, a), median preoptic nucleus (MEPO, a), anteroventral preoptic nucleus (AVP, b), anteroventral periventricular nucleus (AVPV, b), and medial preoptic region (MPO, b). nNOS immunoreactivity was also detected in the anterior hypothalamic nucleus (AHN, c), lateral hypothalamic area (LHA, c) and supraoptic nucleus (SO, c), with rare neurons also present in the periventricular nucleus of the hypothalamus (PVp, f). nNOS-expressing neurons were also visualized in the paraventricular nucleus of the hypothalamus (PVH, d), the dorsomedial nucleus of the hypothalamus (DMH, e), the ventrolateral part of the ventromedial nucleus of the hypothalamus (VMH, e), the arcuate nucleus of the hypothalamus (ARH, e) and the ventral premammillary nucleus (PMv, f). Sections are counterstained using Hoechst (blue) to visualize cell nuclei and identify the morphological limits of each hypothalamic structure. 3V: third ventricle. Scale bar 5100 lm in (a), (b), (d) and (f), and 200 lm in (c) and (e) colocalize with ERa (70.65% 6 6.8, n 5 3) (Figure 4e ), in agreement with previous reports (Okamura, Yokosuka, & Hayashi, 1994 ). An agedependent increase in the proportion of nNOS cells double-labeled for ERa was detected in the VMH (P11: 32.22 6 1.92%, P23: 47.11 6 1.62%, n 5 3-4 per group, Kruskall-Wallis test, P 5 0.018; Dunn's multiple-comparison test, P11 vs. adult: P < 0.05) (Figure 3c ). In the DMH, ERa-containing cells were scattered and weakly labeled, as opposed to the large population of nNOS expressing neurons residing in this nucleus; only occasional colocalization between nNOS and ERa immunoreactivities was detected at any stage of postnatal development (Figures 3c and 4c) . In the PMv, where there is an abundant population of nNOS neurons, only sporadic ERa immunoreactivity was detected, although some double-labeled cells could be found (Figures 3d and 4f ).
| Differential expression of Vglut2 and Vgat promoters in hypothalamic nNOS neurons
Immunolabeling for nNOS in the hypothalamus of adult female EYFP 
| Distinct populations of nNOS neurons morphologically interact with hypothalamic GnRH neuronal cell bodies and nerve terminals
Cellular analyses of double-labeled material showed that most nNOS neurons morphologically associated with GnRH cell bodies or dendrites in the OV/MEPO expressed Vglut2 promoter activity (Figure 6a-g ).
Interestingly, analysis of Eyfp labeling showed that Vglut2 promoter activity was also expressed in the majority (but not all) of the GnRH immunoreactive cells of the OV/MEPO (Figure 6a-g ). These results are in agreement with previous studies attributing a glutamatergic identity to GnRH neurons (Hrabovszky, Turi, Kallo, & Liposits, 2004) .
The use of the Gad67::Gfp G42 animal model, in which green fluorescent protein (GFP) is specifically expressed in parvalbuminimmunoreactive GABA neurons (GFP
Gad67
) (Ango et al., 2004; Chattopadhyaya et al., 2004) , allowed us to explore the specific relationship between this subpopulation of GABAergic neurons and nNOS-and GnRH-expressing cells in the hypothalamus. Although a large population of GFP Gad67 neurons was seen to reside in the medial septal nucleus (MS) (data not shown), an extra-hypothalamic structure known to receive reciprocal connections from the hypothalamus (Risold & Swanson, 1997; Swanson & Cowan, 1979) , relatively few GFP
neurons from the G42 mouse line were detected in the hypothalamus.
While GFP Gad67 fibers were abundantly distributed in the OV/MEPO, GFP-positive neuronal somata were only rarely seen in the preoptic region. GFP Gad67 neurons in the OV/MEPO were never seen to coexpress the nNOS protein (Figure 6h,i) . Remarkably, however, several of the GFP Gad67 neuronal somata were found to be immunoreactive for GnRH (Figure 6i-n) , raising the possibility that at least a portion of the non-glutamatergic GnRH neurons that were identified in EYFP Vglut2 mice could be parvalbumin-expressing GABAergic neurons. In contrast, in the ARH, 30% of the GFP Gad67 neurons were seen to express nNOS-immunoreactivity in adult mice. Projections from GnRH neurons were observed approaching some of these nNOS-immunoreactive GFP Gad67 neurons (inset Figure 6i-t) . While EYFP Vgat signal was 
| DISCUSSION
In the present study, we used immunohistochemistry to systematically examine the distribution of nNOS in the preoptic and tuberal regions of the hypothalamus in female mice. In addition, several sites in which nNOS expression changes during postnatal life were identified. Finally, according to their distinct neurochemical repertoires, three main populations of hypothalamic nNOS neurons were identified. Our findings are consistent with the proposed role of nNOS in regulating the neuroendocrine control of reproduction, and suggest that hypothalamic NO could also be involved in regulating body weight homeostasis.
It is well established that gonadal estrogens act via the brain to control the secretion of gonadotropins (follicle stimulating hormone, FSH, and luteinizing hormone, LH) by the pituitary gland and thus control gonadal growth, folliculogenesis and ovulation in females. The onset of this feedback mechanism occurs after mini-puberty, which consists of an FSH surge occurring at P12 that triggers the growth of the first pool of ovarian follicles that will ovulate at puberty (Prevot, 2015) , concomitant with the decrease in circulating levels of the estrogen-binding a-fetoprotein between P12 and P16 (Bakker et al., 2006; Germain, Campbell, & Anderson, 1978) . The present study demonstrates that most nNOS neuronal populations expressing ERa in the adult hypothalamus already express ERa at P11. Intriguingly, however, our results show that nNOS expression in the ARH, in which ERa immunoreactivity is seen during the infantile period at P11, only becomes apparent during the juvenile period, at P23. The issues of whether circulating estrogens drive nNOS expression in the ARH and whether nNOS expression in ERa-immunoreactive cells is required for the onset of estradiol negative feedback on the HPG axis, require clarification.
Our double-immunolabeling data reveal that the most densely packed nNOS population of the hypothalamus occurs in the OV/ MEPO, a brain region in which NO-producing neurons are known to play a role in regulating GnRH neuronal activity and function (Bellefontaine et al., 2014; Clasadonte et al., 2008; d'Anglemont de Tassigny et al., 2007; Hanchate et al., 2012; Messina et al., 2016) . Consistent with the critical involvement of estradiol in the control of nNOS hormones including gonadal steroids (Langlet, Mullier, Bouret, Prevot, & Dehouck, 2013; Prager-Khoutorsky & Bourque, 2015) and are well positioned to convey this information to GnRH neurons.
The present study also shows that in addition to being expressed in the OV/MEPO and the ARH, nNOS is also abundantly expressed in other hypothalamic nuclei such as the PVH, VMH, and DMH, as well as in the LHA. Each of these nuclei and areas is known, like the ARH and more recently the MEPO, to be deeply involved in the regulation of energy homeostasis (Cone et al., 2001; Elmquist, Coppari, Balthasar, Ichinose, & Lowell, 2005; Saper, Chou, & Elmquist, 2002; Sawchenko, 1998; Schwartz, Woods, Porte, Seeley, & Baskin, 2000; Sutton, Myers, & Olson, 2016; Yu et al., 2016; Zhang et al., 2011) . Consistent with the potential role of nNOS in metabolic pathways, recent reports have shown that mice lacking the receptor for the anorexigenic hormone leptin specifically in nNOS neurons display hyperphagic obesity (Leshan et al., 2012) , and that introducing an nNOS-null mutation into leptindeficient mice significantly reduces the obese phenotype of these mice (Bellefontaine et al., 2014) . In particular, PVH neurons containing nNOS have been shown to be critically involved in PVH regulated energy balance (Sutton et al., 2016) since selective activation of nNOS neurons in the PVH is found to regulate both feeding and energy expenditure (Sutton et al., 2014) . Interestingly, our present results
show that the great majority of nNOS cells in the VMH also express the receptor for estradiol, which, in addition to its critical functions as a reproductive hormone, plays a vital role in the regulation of energy balance (Gao et al., 2007; Park et al., 2011) . In contrast, nNOS/ERa double-labeled cells are rarely seen in the DMH or the LHA, or in the ventral premammillary nucleus, which has been shown to relay metabolic information to GnRH neurons (Donato et al., 2011) , despite its abundant nNOS expression.
On the whole, our current findings on nNOS expression in adult female mice agree well with previous observations in the rat hypothalamus (Herbison et al., 1996; Yamada, Emson, & Hokfelt, 1996) and the mouse brain (Gotti, Sica, Viglietti-Panzica, & Panzica, 2005; Sica, Martini, Viglietti-Panzica, & Panzica, 2009) , with some exceptions. Most differences observed between the studies involved differences in signal intensity. For example, although Gotti et al. reported weak nNOS staining in the OV, we detected heavy staining in this area, with nNOS neurons being densely packed. These apparent discrepancies may be due to sex differences, since nNOS expression in the hypothalamus has been shown to be sexually dimorphic (Knoll, Wolfe, & Tobet, 2007) .
The present study also demonstrates that most nNOS neurons of the hypothalamus possess a glutamatergic phenotype, but that nNOS neurons of the ARH appear to be GABAergic. Notably, the ARH is the only hypothalamic nucleus in which nNOS is found in a subpopulation of GABAergic interneurons expressing parvalbumin and usually found in the medial septum, the cortical areas, and the cerebellum (Ango et al., 2004; Chattopadhyaya et al., 2004) . Although no study has characterized the morphology and electrophysiology of these cells population, further investigation is needed to define their specific role in the ARH circuit function. The prevalence of glutamatergic signaling in nNOS-expressing neurons of the OV/MEPO suggests that the glutamate-mediated activation of nNOS via the NMDA receptor, responsible for the Ca 21 influx activating the enzyme (Garthwaite et al., 1988) , could occur locally through autocrine and paracrine pathways and that input from other brain regions may play only a modulatory role. While glutamatergic nNOS neurons in the OV/MEPO are intermingled with GnRH neuronal cells bodies, most of which are also glutamatergic (only a few express Gad67) (Dumalska et al., 2008) , GABAergic nNOS neurons in the ARH appear to be morphologically associated with GnRH axon terminals.
In conclusion, this immunohistochemical study provides detailed and novel information about the spatial and temporal distribution of Colocalization of the enhanced yellow fluorescent protein (YFP-IR, green) is evident in both nNOS-immunoreactive cells (purple; b, f) and GnRH-immunoreactive neurons (red; c, g) in the preoptic region of adult female EYFP Vglut2 mice (a-g). Expression of green fluorescent protein (GFP) driven by the Gad67 promoter is absent in nNOS-immunoreactive cells (purple) of the preoptic region (h-i), while it is occasionally expressed in GnRH-immunoreactive neurons (red; i-n). In the arcuate nucleus of the adult female hypothalamus (ARH), nNOSimmunoreactive neurons expressing GFP Gad67 (o-p, t) are surrounded by GnRH-immunoreactive fibers (red; q, s, t). Scale bar 5 100 lm (25 lm in insets) nNOS and ERa in the female mouse hypothalamus. In addition, it reveals critical sites in which nNOS expression changes during postnatal development, and identifies distinct subsets of hypothalamic nNOS neurons according to their neurochemical phenotype (Figure 7 ).
These data support the role of hypothalamic nNOS in the regulation of reproductive and energy homeostasis both in developing and mature animals (Chachlaki, Garthwaite, & Prevot, 2017) .
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